BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34390620)

  • 1. Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study.
    de Nie I; Wiepjes CM; de Blok CJM; van Moorselaar RJA; Pigot GLS; van der Sluis TM; Barbé E; van der Voorn P; van Mello NM; Huirne J; den Heijer M
    BJU Int; 2022 Apr; 129(4):491-497. PubMed ID: 34390620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin cancer incidence in transgender individuals receiving gender-affirming hormone treatment: a nationwide cohort study in the Netherlands.
    Rahmat A; De Nie I; Wiepjes CM; Den Heijer M; Rustemeyer T; De Blok CJM; Dreijerink KMA
    Int J Dermatol; 2023 Jul; 62(7):882-887. PubMed ID: 37140088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fracture Risk in Trans Women and Trans Men Using Long-Term Gender-Affirming Hormonal Treatment: A Nationwide Cohort Study.
    Wiepjes CM; de Blok CJ; Staphorsius AS; Nota NM; Vlot MC; de Jongh RT; den Heijer M
    J Bone Miner Res; 2020 Jan; 35(1):64-70. PubMed ID: 31487065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment.
    de Nie I; de Blok CJM; van der Sluis TM; Barbé E; Pigot GLS; Wiepjes CM; Nota NM; van Mello NM; Valkenburg NE; Huirne J; Gooren LJG; van Moorselaar RJA; Dreijerink KMA; den Heijer M
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3293-9. PubMed ID: 32594155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
    de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
    BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort.
    Pathak A; Adams CD; Loud JT; Nichols K; Stewart DR; Greene MH
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1614-21. PubMed ID: 26265202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study.
    de Blok CJ; Dijkman BA; Wiepjes CM; Konings IR; Dreijerink KM; Barbé E; den Heijer M
    Breast; 2021 Jun; 57():118-122. PubMed ID: 33831630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
    J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time trends and occupational variation in the incidence of testicular cancer in the Nordic countries.
    Ylönen O; Jyrkkiö S; Pukkala E; Syvänen K; Boström PJ
    BJU Int; 2018 Sep; 122(3):384-393. PubMed ID: 29460991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational age at birth and risk of testicular cancer.
    Crump C; Sundquist K; Winkleby MA; Sieh W; Sundquist J
    Int J Cancer; 2012 Jul; 131(2):446-51. PubMed ID: 22314417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired semen quality in trans women: prevalence and determinants.
    de Nie I; Meißner A; Kostelijk EH; Soufan AT; Voorn-de Warem IAC; den Heijer M; Huirne J; van Mello NM
    Hum Reprod; 2020 Jul; 35(7):1529-1536. PubMed ID: 32613241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women.
    de Nie I; Mulder CL; Meißner A; Schut Y; Holleman EM; van der Sluis WB; Hannema SE; den Heijer M; Huirne J; van Pelt AMM; van Mello NM
    Hum Reprod; 2022 Jan; 37(2):297-308. PubMed ID: 34791270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
    Hartmann JT; Fossa SD; Nichols CR; Droz JP; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
    J Natl Cancer Inst; 2001 Nov; 93(22):1733-8. PubMed ID: 11717334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and distribution of primary site among gender minority cancer patients: An analysis of U.S. national surveillance data.
    Nash R; Ward KC; Jemal A; Sandberg DE; Tangpricha V; Goodman M
    Cancer Epidemiol; 2018 Jun; 54():1-6. PubMed ID: 29529446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria.
    de Blok CJ; Wiepjes CM; van Velzen DM; Staphorsius AS; Nota NM; Gooren LJ; Kreukels BP; den Heijer M
    Lancet Diabetes Endocrinol; 2021 Oct; 9(10):663-670. PubMed ID: 34481559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
    Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
    J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy.
    Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM
    Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of second gonadal cancers in women and children with germ cell tumors.
    Liao ZW; Rodrigues MC; Poynter JN; Amatruda JF; Rodriguez-Galindo C; Frazier AL
    Cancer; 2016 Jul; 122(13):2076-82. PubMed ID: 27152727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Testicular Cancer in Transfeminine Patients following Vaginoplasty with Orchidectomy.
    Bonapace-Potvin M; Bijou-Coulon S; Medor MC; Brassard P; Bélanger M
    Plast Reconstr Surg Glob Open; 2022 Apr; 10(4):e4051. PubMed ID: 35450259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.